Avidian Wealth Enterprises’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-12,000
Closed -$199K 480
2022
Q3
$199K Buy
12,000
+1,000
+9% +$22.5K 0.01% 393
2022
Q2
$219K Buy
11,000
+1,000
+10% +$20.2K 0.02% 407
2022
Q1
$276K Buy
10,000
+5,000
+100% +$143K 0.02% 406
2021
Q4
$206K Hold
5,000
0.01% 492
2021
Q3
$232K Buy
+5,000
New +$218K 0.02% 337

Other funds holding VCYT

Avidian Wealth Enterprises's VCYT Position: Q4 2022 in Review

Avidian Wealth Enterprises sold out of Veracyte (VCYT) in Q4 2022, closing a stake of 12,000 shares — an estimated $199K sold.

Avidian Wealth Enterprises first reported a position in VCYT in Q3 2021 and held it in 5 quarters. The position peaked at $276K in Q1 2022. 223 funds tracked by Wall St. Rank hold VCYT as of Q4 2022.

  • Avidian Wealth Enterprises reported no remaining Veracyte position as of Q4 2022 after selling out during the quarter.
  • Avidian Wealth Enterprises sold 12,000 Veracyte shares in Q4 2022, an estimated $199K.
  • Avidian Wealth Enterprises first reported a position in Veracyte in Q3 2021 and held it in 5 quarters.
  • Avidian Wealth Enterprises's Veracyte position peaked at $276K in Q1 2022.
  • 223 funds tracked by Wall St. Rank held Veracyte as of Q4 2022.

Based on Avidian Wealth Enterprises's 13F filing for Q4 2022, filed 6 Feb 2023.